Humer Kristian
SEC insider (Form 3/4/5 filer). CIK 0001872280. Chief Financial Officer at 4D Molecular Therapeutics, Inc. (FDMT) and 2 other issuers. 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in CAMBRIDGE, MA.
Companies Humer Kristian has filed insider reports for
- 4D Molecular Therapeutics, Inc. (FDMT): Officer, Chief Financial Officer
- Foghorn Therapeutics Inc. (FHTX): Officer, Chief Financial Officer
- Sensei Biotherapeutics, Inc. (SNSE): Director
Humer Kristian
CIK: 0001872280
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 9, 2025FDMT
4D Molecular Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
480K shares- - May 21, 2025SNSE
Sensei Biotherapeutics, Inc.
AwardDirectStock Option (Right to Buy)
19K shares- - Jan 22, 2025FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Option (right to buy)
120K shares at avg. $4.37-
1-3 of 3 transactions